TEM β-lactamase confers bacteria with resistance to many antibiotics and rapidly evolves activity against new drugs. However, functional changes are not easily explained by differences in crystal structures. We employ Markov state models to identify hidden conformations and explore their role in determining TEM’s specificity. We integrate these models with existing drug-design tools to create a new technique, called Boltzmann docking, which better predicts TEM specificity by accounting for conformational heterogeneity. Using our MSMs, we identify hidden states whose populations correlate with activity against cefotaxime. To experimentally detect our predicted hidden states, we use rapid mass spectrometric footprinting and confirm our models’ prediction that increased cefotaxime activity correlates with reduced Ω-loop flexibility. Finally, we design novel variants to stabilize the hidden cefotaximase states, and find their populations predict activity against cefotaxime in vitro and in vivo. Therefore, we expect this framework to have numerous applications in drug and protein design.
drugs               0.8202870027774971^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

cefotaxime                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cefotaxime            

bacteria                      0.9999721468854034^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Bacteria              

TEM                           0.9999999999992042^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Transmission_electron_microscopy

TEM                           0.9999999999992042^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Transmission_electron_microscopy

TEM                           0.9999999999992042^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Transmission_electron_microscopy

MSMs                          0.9999999447250063^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Men_who_have_sex_with_men

'                             0.9999992614158827^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Apostrophe            

accounting                    0.9833072875001243^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Accountancy           

mass spectrometric            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Mass_spectrometry     

drug                          0.8443026447498753^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

crystal structures            0.9999996906640741^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/X-ray_crystallography 

conformations                 0.9999871175299287^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Protein_structure     

heterogeneity                 0.9999999999994316^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Homogeneity_and_heterogeneity

specificity                   0.9983831258245921^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sensitivity_and_specificity

Markov                        0.9064305437091428^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Markov_chain          

cefotaxime                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cefotaxime            

specificity                   0.9983831258245921^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sensitivity_and_specificity

antibiotics                   0.99994244148652^^http://www.w3.org/2001/XMLSchema#double             http://dbpedia.org/resource/Antibacterial         

β-lactamase                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Beta-lactamase        

Boltzmann                     0.9999995266233538^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Boltzmann_distribution

protein design                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Protein_design        

resistance                    0.9286865966964089^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug_resistance       

cefotaxime                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Cefotaxime            

